What Researchers Did
Researchers conducted a contemporary review of literature published between April 2015 and March 2018 on the management of radiation-induced hemorrhagic cystitis.
What They Found
The review identified 13 clinical studies and two new clinical trial protocols during the period of interest. Most studies were retrospective, supporting hyperbaric oxygen (HBO) therapy as a well-tolerated and effective first-line treatment. While formalin and surgery were effective but potentially morbid last-line options, no consensus exists on a primary approach beyond symptomatic measures.
What This Means for Canadian Patients
Canadian patients experiencing radiation-induced hemorrhagic cystitis may find hyperbaric oxygen therapy to be a well-tolerated and effective initial treatment option. However, the optimal treatment sequence remains unclear, and local availability often dictates the choice of therapy.
Canadian Relevance
This review is relevant for Canadian healthcare providers and patients as it summarizes current management options for radiation-induced hemorrhagic cystitis.
Study Limitations
A significant limitation is the scarcity of prospective studies, which hinders the ability to establish a clear hierarchy for therapeutic interventions.